RaySearch Laboratories AB (publ)
STO:RAY B

Watchlist Manager
RaySearch Laboratories AB (publ) Logo
RaySearch Laboratories AB (publ)
STO:RAY B
Watchlist
Price: 204.5 SEK 0.25%
Market Cap: 7B SEK
Have any thoughts about
RaySearch Laboratories AB (publ)?
Write Note

RaySearch Laboratories AB (publ)
Total Current Liabilities

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

RaySearch Laboratories AB (publ)
Total Current Liabilities Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Total Current Liabilities CAGR 3Y CAGR 5Y CAGR 10Y
RaySearch Laboratories AB (publ)
STO:RAY B
Total Current Liabilities
kr614.1m
CAGR 3-Years
13%
CAGR 5-Years
13%
CAGR 10-Years
N/A
ContextVision AB
OSE:CONTX
Total Current Liabilities
kr22.9m
CAGR 3-Years
2%
CAGR 5-Years
-1%
CAGR 10-Years
5%
M
Mentice AB
STO:MNTC
Total Current Liabilities
kr161.4m
CAGR 3-Years
29%
CAGR 5-Years
20%
CAGR 10-Years
N/A
O
Ortivus AB
STO:ORTI B
Total Current Liabilities
kr42.2m
CAGR 3-Years
-3%
CAGR 5-Years
11%
CAGR 10-Years
N/A
Sectra AB
STO:SECT B
Total Current Liabilities
kr1.6B
CAGR 3-Years
31%
CAGR 5-Years
23%
CAGR 10-Years
N/A
K
Kontigo Care AB
STO:KONT
Total Current Liabilities
kr12m
CAGR 3-Years
9%
CAGR 5-Years
10%
CAGR 10-Years
N/A
No Stocks Found

RaySearch Laboratories AB (publ)
Glance View

Market Cap
7B SEK
Industry
Health Care

RaySearch Laboratories AB is a medical technology company, which engages in the development of software solutions for improved radiation therapy of cancer. The company is headquartered in Stockholm, Stockholm. The company markets and sells its products mainly in the United States and in Europe through license agreements with medical technology companies and scientific institutions. As of December 31, 2011, 15 of the Company’s products were launched, including the software platform ORBIT (optimization of radiation therapy beams by iterative technique), which is available in its main products, and is a non-clinical system which functions as a research and development environment. Additionally, its solutions include software for optimizing Intensity Modulated Radiation Therapy (IMRT) plans for photons, adaptive technology for IMRT treatments and software for proton treatments. The Company’s commercial partners are Philips, Nucletron and IBA Dosimetry, among others. In April 2014, it established a German subsidiary, RaySearch Germany GmbH.

RAY B Intrinsic Value
219.97 SEK
Undervaluation 7%
Intrinsic Value
Price

See Also

What is RaySearch Laboratories AB (publ)'s Total Current Liabilities?
Total Current Liabilities
614.1m SEK

Based on the financial report for Dec 31, 2023, RaySearch Laboratories AB (publ)'s Total Current Liabilities amounts to 614.1m SEK.

What is RaySearch Laboratories AB (publ)'s Total Current Liabilities growth rate?
Total Current Liabilities CAGR 5Y
13%

Over the last year, the Total Current Liabilities growth was 0%. The average annual Total Current Liabilities growth rates for RaySearch Laboratories AB (publ) have been 13% over the past three years , 13% over the past five years .

Back to Top